TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 41 filers reported holding TREVI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62,021 | -8.8% | 28,450 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $67,996 | +29.2% | 28,450 | 0.0% | 0.01% | +14.3% |
Q1 2023 | $52,633 | -4.1% | 28,450 | 0.0% | 0.01% | -12.5% |
Q4 2022 | $54,909 | +24.8% | 28,450 | 0.0% | 0.01% | +14.3% |
Q3 2022 | $44,000 | -45.0% | 28,450 | 0.0% | 0.01% | -41.7% |
Q2 2022 | $80,000 | +35.6% | 28,450 | +6.6% | 0.01% | +50.0% |
Q1 2022 | $59,000 | – | 26,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 11,370,376 | $24,787,420 | 1.91% |
Fairmount Funds Management LLC | 5,163,287 | $11,255,966 | 1.35% |
Opaleye Management Inc. | 1,705,900 | $3,718,862 | 1.21% |
Frazier Life Sciences Management, L.P. | 6,881,090 | $15,000,776 | 1.00% |
VR Adviser, LLC | 3,422,397 | $7,460,825 | 0.78% |
SILVERARC CAPITAL MANAGEMENT, LLC | 927,415 | $2,021,765 | 0.61% |
Rubric Capital Management LP | 5,684,420 | $12,392,036 | 0.46% |
Tejara Capital Ltd | 180,227 | $392,895 | 0.22% |
PFS Partners, LLC | 100,000 | $218,000 | 0.19% |
WealthTrust Axiom LLC | 93,500 | $203,830 | 0.07% |